Nissay Asset Management Corp Japan ADV Buys 857 Shares of Avantor, Inc. (NYSE:AVTR)

Nissay Asset Management Corp Japan ADV lifted its stake in Avantor, Inc. (NYSE:AVTR) by 1.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 82,523 shares of the company’s stock after acquiring an additional 857 shares during the period. Nissay Asset Management Corp Japan ADV’s holdings in Avantor were worth $1,767,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in AVTR. MassMutual Private Wealth & Trust FSB grew its holdings in Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after buying an additional 625 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in Avantor by 106.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after buying an additional 830 shares during the last quarter. Global Retirement Partners LLC grew its holdings in Avantor by 76.7% in the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after buying an additional 1,067 shares during the last quarter. UMB Bank n.a. grew its holdings in Avantor by 56.3% in the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after buying an additional 1,074 shares during the last quarter. Finally, AlphaQuest LLC acquired a new stake in Avantor in the 4th quarter valued at approximately $65,000. 95.08% of the stock is owned by institutional investors.

Avantor Price Performance

Shares of NYSE:AVTR opened at $13.40 on Friday. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $9.13 billion, a PE ratio of 12.88, a PEG ratio of 1.55 and a beta of 1.09. Avantor, Inc. has a 1-year low of $11.82 and a 1-year high of $28.00. The business’s 50 day moving average is $14.76 and its 200-day moving average is $18.59.

Avantor (NYSE:AVTR) last posted its earnings results on Friday, April 25th. The company reported $0.23 EPS for the quarter, hitting the consensus estimate of $0.23. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a return on equity of 12.17% and a net margin of 10.49%. Avantor’s revenue was down 5.9% on a year-over-year basis. During the same quarter last year, the company earned $0.22 EPS. Sell-side analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current year.

Insider Buying and Selling

In other Avantor news, EVP James Bramwell sold 3,758 shares of Avantor stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the transaction, the executive vice president now owns 87,379 shares in the company, valued at approximately $1,531,753.87. The trade was a 4.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Steven W. Eck sold 4,907 shares of Avantor stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the transaction, the chief accounting officer now owns 40,604 shares of the company’s stock, valued at approximately $711,788.12. The trade was a 10.78% decrease in their position. The disclosure for this sale can be found here. 1.20% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

AVTR has been the topic of a number of research analyst reports. Morgan Stanley lowered Avantor from an “overweight” rating to an “equal weight” rating in a report on Tuesday, April 29th. Royal Bank of Canada lowered their target price on Avantor from $24.00 to $20.00 and set an “outperform” rating on the stock in a report on Monday, April 28th. Robert W. Baird lowered their target price on Avantor from $21.00 to $17.00 and set an “outperform” rating on the stock in a report on Monday, April 28th. Cowen lowered Avantor from a “buy” rating to a “hold” rating in a report on Monday, April 28th. Finally, Raymond James reaffirmed an “outperform” rating and issued a $24.00 target price (down previously from $26.00) on shares of Avantor in a report on Monday, February 10th. Seven investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $18.88.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.